March 17, 2020 SALT LAKE CITY–(BUSINESS WIRE)–Molecular diagnostics company XCR Diagnostics has successfully completed the verification and validation of its XCR® COVID-19 assay and can now petition the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA). The company’s faster COVID-19 test leverages its patented rapid chemistry format to enable laboratories to double or even triple …